Bristol Myers Squibb Stock Investor Sentiment

BMY Stock  USD 53.25  0.70  1.33%   
Slightly above 53% of Bristol Myers' investor base is interested to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are impartial at this time. Bristol Myers' investor sentiment overview provides quick insight into current market opportunities from investing in Bristol Myers Squibb. The current market sentiment, together with Bristol Myers' historical and current headlines, can help investors time the market. In addition, many technical investors use Bristol-Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

47

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bristol Myers' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bristol Myers Squibb.
Bristol Myers stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bristol daily returns and investor perception about the current price of Bristol Myers Squibb as well as its diversification or hedging effects on your existing portfolios.

Bristol Historical Sentiment

Although Bristol Myers' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bristol, such as negative comments on social media and news outlets, may cause fear in the market and push Bristol Myers' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bristol.
  

Bristol Myers Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Bristol Myers can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bristol-Myers Squibb Historical Investor Sentiment

Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bristol Myers news discussions. The higher the estimate score, the more favorable the investor's outlook on Bristol Myers.

Bristol Myers Maximum Pain Price across 2024-03-28 Option Contracts

Bristol Myers' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Bristol Myers close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Bristol Myers' options.
over two weeks ago at www.macroaxis.com         
Disposition of 1050 shares by Hoch Lynelle of Bristol Myers subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Orion Capital Management LLC Invests 148,000 in Bristol-Myers Squibb
news
over two weeks ago at thelincolnianonline.com         
Moneta Group Investment Advisors LLC Sells 4,159 Shares of Bristol-Myers Squibb
news
over two weeks ago at finance.yahoo.com         
Double Life of Key Immune Protein Reveals New Strategies for Treating Cancer and Autoimmune Diseases
Yahoo News
over two weeks ago at businesswire.com         
Asha Therapeutics to Present at ADPD 2024 International Conference and Announces Clinical Developmen...
businesswire News
over two weeks ago at finance.yahoo.com         
Bristol-Myers Squibb Will Pay A Dividend Of 0.60
Yahoo News
over two weeks ago at finance.yahoo.com         
Asha Therapeutics to Present at ADPD 2024 International Conference and Announces Clinical Developmen...
Yahoo News
over two weeks ago at businesswire.com         
Asha Therapeutics to Present at ADPD 2024 International Conference and Announces Clinical Developmen...
businesswire News
over two weeks ago at finance.yahoo.com         
Bristol Myers Squibb Stock Dips While Market Gains Key Facts
Yahoo News
over two weeks ago at investing.com         
Opdivo combination therapy approved for bladder cancer
Investing News at Macroaxis
over two weeks ago at zacks.com         
Bristol Myers Squibb Stock Dips While Market Gains Key Facts
zacks News
over two weeks ago at businesswire.com         
U.S. Food and Drug Administration Approves Opdivo , in Combination with Cisplatin and Gemcitabine, f...
businesswire News
over two weeks ago at businesswire.com         
U.S. Food and Drug Administration Approves Opdivo , in Combination with Cisplatin and Gemcitabine, f...
businesswire News
over two weeks ago at finance.yahoo.com         
U.S. Food and Drug Administration Approves Opdivo , in Combination with Cisplatin and Gemcitabine, f...
Yahoo News
over two weeks ago at thelincolnianonline.com         
Stonebridge Capital Advisors LLC Has 10.34 Million Stake in Bristol-Myers Squibb
news
Far too much social signal, news, headlines, and media speculation about Bristol Myers that are available to investors today. That information is available publicly through Bristol media outlets and privately through word of mouth or via Bristol internal channels. However, regardless of the origin, that massive amount of Bristol data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bristol Myers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bristol Myers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bristol Myers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bristol Myers alpha.

Bristol Myers Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
 
Bristol Myers dividend paid on 1st of February 2024
02/01/2024
1
Bristol-Myers Squibb Will Pay A Dividend Of 0.60
03/08/2024
2
FDA to focus on early deaths in meeting on broader CAR-T use in myeloma
03/13/2024
3
BAE Systems Eyes at Least 4 Billion to Fund Ball Aerospace Purchase
03/18/2024
4
PureTech Proposes 100 Million Capital Return
03/19/2024
5
Opdivo and Yervoy combo extends survival in liver cancer study
03/20/2024
6
Bristol-Myers Squibb Is Due To Pay A Dividend Of 0.60
03/21/2024
7
Premiership Bristol 52-21 Northampton Seven-try Bristol end league leaders Saints winning run
03/22/2024
8
Bristol-Myers Squibb Co at TD Cowen Health Care Conference Transcript
03/25/2024
9
SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
03/27/2024
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.